Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» t-aNK
t-aNK
NantKwest and ImmunityBio to initiate a phase 2 study of immunotherapy for metastatic pancreatic cancer
Pharmaceutical Business Review
Fri, 05/15/20 - 10:29 am
NantKwest
clinical trials
t-aNK
metastatic prostate cancer